Related Experiment Video
Updated: Feb 10, 2026

Generation of Scalable, Metallic High-Aspect Ratio Nanocomposites in a Biological Liquid Medium
Published on: July 8, 2015
Biological aspects of chondrosarcoma: Leaps and hurdles
Benoîte Mery1, Sophie Espenel2, Jean-Baptiste Guy2
1Department of Medical Oncology, Lucien Neuwirth Cancer Institute, St Priest en Jarez, France.
Abstract:
Chondrosarcomas are characterized by their chemo- and radioresistance leading to a therapeutic surgical approach which remains the only available treatment with a 10-year survival between 30% and 80% depending on the grade. Non-surgical treatments are under investigation and rely on an accurate biological understanding of drug resistance mechanisms. Novel targeted therapy which represents a new relevant therapeutic approach will open new treatment options by targeting several pathways responsible for processes of proliferation and invasion. Survival pathways such as PI3K, AKT, mTOR and VEGF have been shown to be involved in proliferation of chondrosarcoma cells and antiapoptotic proteins may also play a relevant role. Other proteins such as p53 or COX2 have been identified as potential new targets. This review provides an insight into the biological substantial treatment challenges of CHS and focuses on improving our understanding of CH biology through an overview of major signaling pathways that could represent targets for new therapeutic approaches.
Insights
Chondrosarcoma treatment faces challenges due to chemoresistance, necessitating surgical intervention. Understanding resistance mechanisms and targeting key pathways like PI3K/AKT/mTOR offers new therapeutic avenues for chondrosarcoma (CHS).
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Chondrosarcomas (CHS) exhibit significant chemo- and radioresistance.
- Current treatment relies primarily on surgery, with survival rates varying by grade.
- Non-surgical treatment strategies require a deeper understanding of resistance mechanisms.
Purpose of the Study:
- To review the biological challenges in treating chondrosarcoma.
- To explore major signaling pathways involved in chondrosarcoma proliferation and invasion.
- To identify potential molecular targets for novel therapeutic approaches.
Main Methods:
- Literature review of chondrosarcoma biology and treatment resistance.
- Analysis of key signaling pathways implicated in chondrosarcoma progression.
- Identification of potential therapeutic targets based on biological understanding.
Main Results:
- Survival pathways (PI3K, AKT, mTOR, VEGF) are crucial for chondrosarcoma cell proliferation.
- Antiapoptotic proteins and targets like p53 and COX2 are implicated in resistance.
- Targeted therapies offer potential new treatment options.
Conclusions:
- Improved understanding of chondrosarcoma biology is essential for developing effective non-surgical treatments.
- Targeting specific signaling pathways and proteins presents a promising strategy for novel chondrosarcoma therapies.
- Novel targeted therapies could overcome chemo- and radioresistance in chondrosarcoma.
Related Concept Videos
What is Conservation Biology?
Quantitative Aspects of Drug-Receptor Interaction
Biological Effects of Radiation
Synthetic Biology
Golden rice
Golden rice is a genetically modified...
Biological Causes of Schizophrenia
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
Biological Influences on Intelligence

